论文信息 - Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase I/II CheckMate 032 study. - 字舞流文

Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase I/II CheckMate 032 study.

P. Sharma | P. Ott | J. Rosenberg | C. Harbison | E. Chan | M. Morse | A. Azrilevich | D. Jaeger | R. Pillai | E. Calvo | P. Bono | Joseph Kim | P. Spiliopoulou | F. Braud | D. Le | Chen-Sheng Lin | M. Tschaika | Joseph W. Kim | Alex Azrilevich | E. Chan